Search Results - "Marrie, Ruth Ann"

Refine Results
  1. 1

    A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? by Forbes, Jessica D, Chen, Chih-Yu, Knox, Natalie C, Marrie, Ruth-Ann, El-Gabalawy, Hani, de Kievit, Teresa, Alfa, Michelle, Bernstein, Charles N, Van Domselaar, Gary

    Published in Microbiome (13-12-2018)
    “…Immune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for…”
    Get full text
    Journal Article
  2. 2

    Comorbidity in multiple sclerosis: implications for patient care by Marrie, Ruth Ann

    Published in Nature reviews. Neurology (01-06-2017)
    “…Comorbidity is common in multiple sclerosis (MS). In this Opinion article, Ruth Ann Marrie discusses how comorbidity affects diagnosis, progression, mortality,…”
    Get full text
    Journal Article
  3. 3

    Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts by Amankwah, Nana, Marrie, Ruth Ann, Bancej, Christina, Garner, Rochelle, Manuel, Douglas G, Wall, Ron, Finès, Philippe, Bernier, Julie, Tu, Karen, Reimer, Kim

    “…The objective of our study was to present model-based estimates and projections on current and future health and economic impacts of multiple sclerosis (MS) in…”
    Get full text
    Journal Article
  4. 4

    Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition by Walton, Clare, King, Rachel, Rechtman, Lindsay, Kaye, Wendy, Leray, Emmanuelle, Marrie, Ruth Ann, Robertson, Neil, La Rocca, Nicholas, Uitdehaag, Bernard, van der Mei, Ingrid, Wallin, Mitchell, Helme, Anne, Angood Napier, Ceri, Rijke, Nick, Baneke, Peer

    Published in Multiple sclerosis (01-12-2020)
    “…Background: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs…”
    Get full text
    Journal Article
  5. 5

    The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review by Marrie, Ruth Ann, Reingold, Stephen, Cohen, Jeffrey, Stuve, Olaf, Trojano, Maria, Sorensen, Per Soelberg, Cutter, Gary, Reider, Nadia

    Published in Multiple Sclerosis Journal (01-03-2015)
    “…Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple…”
    Get full text
    Book Review Journal Article
  6. 6
  7. 7

    Social Determinants of Outcomes in Inflammatory Bowel Disease by Bernstein, Charles N., Walld, Randy, Marrie, Ruth Ann

    Published in The American journal of gastroenterology (01-12-2020)
    “…In a population-based inflammatory bowel disease (IBD) cohort, we aimed to determine whether having lower socioeconomic status (LSS) impacted on outcomes. We…”
    Get full text
    Journal Article
  8. 8

    Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease by Bernstein, Charles N, Hitchon, Carol A, Walld, Randy, Bolton, James M, Sareen, Jitender, Walker, John R, Graff, Lesley A, Patten, Scott B, Singer, Alexander, Lix, Lisa M, El-Gabalawy, Renée, Katz, Alan, Fisk, John D, Marrie, Ruth Ann

    Published in Inflammatory bowel diseases (10-01-2019)
    “…Abstract Background Psychiatric comorbidity in inflammatory bowel disease (IBD) is well known; however, data from a truly representative sample are sparse. We…”
    Get full text
    Journal Article
  9. 9

    Effect of comorbidity on mortality in multiple sclerosis by Marrie, Ruth Ann, Elliott, Lawrence, Marriott, James, Cossoy, Michael, Blanchard, James, Leung, Stella, Yu, Nancy

    Published in Neurology (21-07-2015)
    “…OBJECTIVE:We aimed to compare survival in the multiple sclerosis (MS) population with a matched cohort from the general population, and to evaluate the…”
    Get full text
    Journal Article
  10. 10

    Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study by Wijnands, José Maria Andreas, Zhu, Feng, Kingwell, Elaine, Fisk, John David, Evans, Charity, Marrie, Ruth Ann, Zhao, Yinshan, Tremlett, Helen

    “…ObjectiveLittle is known about disease-modifying treatments (DMTs) for multiple sclerosis (MS) and infection risk in clinical practice. We examined the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Emerging effects of comorbidities on multiple sclerosis by Marrie, Ruth Ann, MD, Horwitz, Ralph I, Prof

    Published in Lancet neurology (01-08-2010)
    “…Summary Although the interaction between comorbidities and chronic diseases is strong, the effect of comorbidities receives little attention in many chronic…”
    Get full text
    Journal Article
  13. 13

    Five years before multiple sclerosis onset: Phenotyping the prodrome by Wijnands, José MA, Zhu, Feng, Kingwell, Elaine, Zhao, Yinshan, Ekuma, Okechukwu, Lu, Xinya, Evans, Charity, Fisk, John D, Marrie, Ruth Ann, Tremlett, Helen

    Published in Multiple sclerosis (01-07-2019)
    “…Background: The multiple sclerosis (MS) prodrome is poorly characterized. Objective: To phenotype the MS prodrome via health care encounters. Methods: Using…”
    Get full text
    Journal Article
  14. 14

    A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis by Marrie, Ruth Ann, Reider, Nadia, Cohen, Jeffrey, Stuve, Olaf, Sorensen, Per S, Cutter, Gary, Reingold, Stephen C, Trojano, Maria

    Published in Multiple Sclerosis Journal (01-03-2015)
    “…Background: As new therapies emerge which increase the risk of autoimmune disease it is increasingly important to understand the incidence of autoimmune…”
    Get full text
    Book Review Journal Article
  15. 15
  16. 16

    Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables by Marrie, Ruth Ann, MD, PhD, Dawson, Neal V., MD, Garland, Allan, MD, MA

    Published in Journal of clinical epidemiology (01-05-2009)
    “…Abstract Objective Ordinary least squares (OLS) regression, commonly called linear regression, is often used to assess, or adjust for, the relationship between…”
    Get full text
    Journal Article
  17. 17

    Building and validating trend-based multiple sclerosis case definitions: a population-based cohort study for Manitoba, Canada by Hamm, Naomi C, Marrie, Ruth Ann, Jiang, Depeng, Irani, Pourang, Lix, Lisa

    Published in BMJ open (15-08-2024)
    “…ObjectiveThis study aims to (1) build and validate model-based case definitions for multiple sclerosis (MS) that use trends (ie, trend-based case definitions)…”
    Get full text
    Journal Article
  18. 18

    Switching to second line MS disease-modifying therapies is associated with decreased relapse rate by Marriott, James John, Ekuma, Okechukwu, Fransoo, Randall, Marrie, Ruth Ann

    Published in Frontiers in neurology (06-09-2023)
    “…Background and objectives While randomized, controlled trials (RCTs) are the gold standard for determining treatment efficacy, they do not capture the…”
    Get full text
    Journal Article
  19. 19

    Etiology, effects and management of comorbidities in multiple sclerosis: recent advances by Marrie, Ruth Ann, Fisk, John D, Fitzgerald, Kathryn, Kowalec, Kaarina, Maxwell, Colleen, Rotstein, Dalia, Salter, Amber, Tremlett, Helen

    Published in Frontiers in immunology (2023)
    “…Comorbid conditions commonly affect people with multiple sclerosis (MS). Population-based studies indicate that people with MS have an increased incidence of…”
    Get full text
    Journal Article
  20. 20

    Incidence and prevalence of multiple sclerosis in Europe: a systematic review by Kingwell, Elaine, Marriott, James J, Jetté, Nathalie, Pringsheim, Tamara, Makhani, Naila, Morrow, Sarah A, Fisk, John D, Evans, Charity, Béland, Sarah Gabrielle, Kulaga, Sophie, Dykeman, Jonathan, Wolfson, Christina, Koch, Marcus W, Marrie, Ruth Ann

    Published in BMC neurology (26-09-2013)
    “…Multiple sclerosis (MS) is the most common cause of neurological disability in young adults worldwide and approximately half of those affected are in Europe…”
    Get full text
    Journal Article